ASTRAZENECA PLC (AZN)
Clinical trial NCT06951880 updates: 1. start date: 2025-06-27 → 2026-07-23 2. completion date: 2026-09-24 → 2027-10-25 3. primary completion date: 2026-09-24 → 2027-10-25 4. enrollment: 178 → 160 participants
Clinical trial NCT06951880 updates: 1. start date: 2025-06-27 → 2026-07-23 2. completion date: 2026-09-24 → 2027-10-25 3. primary completion date: 2026-09-24 → 2027-10-25 4. enrollment: 178 → 160 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical